DMVeille DM

Field safety notices: Remel Europe Ltd

Manufacturer registered in EUDAMED: SRN GB-MF-000016733 ; country: United Kingdom

11 authority publications by 3 authorities, from 23 Jul 2019 to 16 Nov 2026.

Latest notice: 16 Nov 2026, AEMPS, Thermo Scientific Remel Haemophilus Influenzae Type a 2ml/VL

Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Remel Europe Ltd or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.

5 distinct corrective actions.

Corrective action: 3 publications by AEMPS, IGJ, from 11 Nov 2026 to 16 Nov 2026

  1. Thermo Scientific Remel Haemophilus Influenzae Type a 2ml/VL
    Models, lots, UDI: Referencia R30166001, UDI-DI 05056080501079

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

  2. Remel Europe Ltd Neisseria meningitidis Gp C 2ml VL

    Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 16 Nov 2026

  3. Remel Europe Ltd Neisseria meningitidis Gp C

    Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 16 Nov 2026

Corrective action: 4 publications by AEMPS, BfArM, IGJ, from 27 Jul 2026 to 21 Aug 2026

  1. Remel Europe Ltd-FSN-2026-007 Remel Europe Ltd-Neisseria meningitidis Gp C 2ml VL

    Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026

  2. Neisseria meningitidis Gp C 2ml/VL, referencia R30166901, UDI-DI 05056080501161

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

  3. Neisseria meningitidis Gp C 2ml/VL

    Source: BfArM – Safety instructions in the field · collected 16 Nov 2026

  4. Neisseria meningitidis Gp C 2ml/VL, referencia R30166901, UDI-DI 05056080501161

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

  1. Oxoid Agglutinating Sera Salmonella 9-O, referencia R30957301, UDI-DI 50560805002708

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

Corrective action: 2 publications by BfArM, IGJ, from 10 Apr 2026 to 10 Apr 2026

  1. Remel Europe Ltd,FSN-2026-002, OXOID Agglutinating Sera. Salmonella 9-0

    Bron: Inspectie Gezondheidszorg en Jeugd (IGJ), veiligheidswaarschuwingen (CC0) · collected 17 Nov 2026

  2. OXOID Agglutinating Sera, Salmonella 9-0

    Source: BfArM – Safety instructions in the field · collected 16 Nov 2026

  1. Remel™ Salmonella paratyphi B-H, referencia R30855201

    Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026

The authorities that published these notices